Genetically predicted levels of beta‐mannosidase (MANBA) decreased risk of ADHD with no evidence of pleiotropic effects despite the finding being mainly driven by a single genetic instrument. This evidence concerns the gene MANBA and attention deficit-hyperactivity disorder.